Axelar

Anti-cancer treatments that target the insulin-like growth factor-1 receptor signalling pathway

placeSolna, Stockholm County, Sweden calendar_todayFounded 2003 groups8 employees language axelar.se

Innovation

11 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 387 times.

YearFilings
20124
20137
20143
20151
20161
20171
20181
20192

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital350%
Other / undisclosed350%
Coming soon